New treatments hold promise of slowing kidney damage

(This Oct. 5 factbox has been corrected to fix the entry on GLP-1 analogues to say the trial will likely be completed in mid-2023, not during the fourth quarter) FRANKFURT (Reuters) – New breakthrough drugs that tackle obesity and kidney damage could m…